What is the step‑by‑step technique for performing rapid sequence intubation, including patient positioning, pre‑oxygenation, selection of induction and paralytic agents, and confirmation of endotracheal tube placement?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rapid Sequence Intubation: Step-by-Step Evidence-Based Protocol

For emergency airway management in critically ill adults, perform rapid sequence intubation using semi-Fowler positioning, 3–5 minutes of pre-oxygenation, etomidate (0.2–0.3 mg/kg) or ketamine (1–2 mg/kg) for induction, followed immediately by succinylcholine (1–1.5 mg/kg) or high-dose rocuronium (0.9–1.2 mg/kg), with endotracheal tube placement confirmed by waveform capnography. 1, 2, 3

Patient Positioning

  • Place the patient in semi-Fowler position (head and torso elevated 25–30°) to reduce aspiration risk and improve first-pass success, despite a modest decrease in first-attempt rate (76.2% vs 85.4% supine). 2, 3

  • In obese patients (BMI >30 kg/m²), use ramped positioning combined with reverse Trendelenburg to extend the safe apnea period, as these patients have twice the risk of intubation complications (fourfold if BMI >40 kg/m²). 3

Pre-Oxygenation Protocol

  • Deliver 3–5 minutes of pre-oxygenation using a well-fitted mask with FiO₂ 1.0 and oxygen flow >10 L/min in a closed-circuit system, targeting end-tidal oxygen concentration >0.9. 2, 3, 4

  • For severe hypoxemia (PaO₂/FiO₂ <150), use noninvasive positive pressure ventilation (NIPPV) with CPAP 5–10 cmH₂O for pre-oxygenation. 2, 3

  • When difficult laryngoscopy is anticipated, apply high-flow nasal oxygen (HFNO) during the procedure to maintain oxygenation. 2, 3

  • For agitated, delirious, or combative patients unable to tolerate pre-oxygenation devices, administer ketamine 1–2 mg/kg IV for medication-assisted pre-oxygenation (delayed sequence intubation), wait 3 minutes while applying oxygen, then proceed with neuromuscular blockade. 1, 2, 3

Induction Agent Selection

Hemodynamically Unstable Patients

  • Etomidate (0.2–0.3 mg/kg IV) is the first-line agent for hemodynamically unstable patients because it produces minimal cardiovascular depression; the 2023 Society of Critical Care Medicine guidelines found no mortality difference compared with other agents (OR 1.17; 95% CI 0.86–1.60). 1, 2

  • Do not exceed 0.3 mg/kg in patients >55 years, as higher doses are associated with oxygen desaturation requiring bag-valve-mask ventilation. 1

Alternative Induction Agents

  • Ketamine (1–2 mg/kg IV) is an acceptable alternative for hemodynamically stable patients and is preferred for agitated patients requiring medication-assisted pre-oxygenation, as it preserves spontaneous respiration and stimulates catecholamine release. 1, 2

  • Avoid ketamine in patients with severe catecholamine depletion (septic shock, cardiogenic shock) because it may cause paradoxical hypotension and cardiac arrest. 1

  • Propofol (2–2.5 mg/kg IV) should be limited to hemodynamically stable patients only, as it causes marked venodilation-related hypotension. 1

Neuromuscular Blocking Agent Selection

  • The Society of Critical Care Medicine issues a Class I strong recommendation that an NMBA be administered immediately after the sedative-hypnotic to prevent awareness during paralysis. 1, 2, 3

First-Line NMBA

  • Succinylcholine (1–1.5 mg/kg IV) provides the fastest onset (45–60 seconds) and shortest duration (5–10 minutes) and is preferred when no contraindications exist. 1, 2

  • Contraindications to succinylcholine include: history of malignant hyperthermia, severe burns or crush injury >24 hours old, spinal cord injury, established renal failure >24 hours, risk of hyperkalemia (particularly boys <9 years), and severe traumatic brain injury (associated with increased mortality OR 4.1; 95% CI 1.2–14.1). 1, 3

Alternative NMBA

  • Rocuronium (0.9–1.2 mg/kg IV for RSI) is the alternative when succinylcholine is contraindicated; at this high dose its onset (≈1 minute) is comparable to succinylcholine, though duration is longer (58–67 minutes). 1, 2

  • Sugammadex must be immediately available when rocuronium is used to permit rapid reversal (≈3 minutes) in "cannot intubate/cannot oxygenate" scenarios. 1, 2, 3

Critical Timing Sequence

  • Administer the sedative-hypnotic agent first, then immediately follow with the NMBA in rapid succession to prevent awareness during paralysis. 1, 2, 3

  • Wait at least 60 seconds after NMBA administration before attempting intubation to ensure full neuromuscular blockade. 1, 3

  • Ensure complete loss of consciousness before any airway manipulation to prevent coughing or awareness. 3

Intubation Technique

  • Videolaryngoscopy should be used whenever available and the operator is skilled, as it improves glottic view, reduces failure rates, and lessens airway trauma. 3, 5

  • Limit intubation attempts to three maximum; exceeding this threshold triggers immediate declaration of "failed intubation" and activation of rescue plans. 3, 5, 6

  • The most experienced operator present should perform the intubation in patients with anticipated difficult airways. 3

  • In cervical spine injury, perform early RSI with manual inline stabilization after removing the anterior portion of the cervical collar, using a bougie during direct laryngoscopy. 3

Confirmation of Endotracheal Tube Placement

  • Waveform capnography must be employed to confirm tracheal placement immediately after tube insertion and continuously throughout mechanical ventilation. 3, 5, 6

  • Confirm functional intravenous access, continuous capnography, operative suction, and a complete airway cart with rescue devices before induction. 3

Post-Intubation Management

  • Immediate post-intubation analgosedation is critical when rocuronium is used, as its 30–60 minute duration outlasts ketamine's dissociative effects, creating a high-risk window for awareness (incidence ≈2.6% without protocolized sedation). 1

  • Assign a dedicated team member—preferably a clinical pharmacist—to manage timing of post-intubation analgosedation and prevent the awareness window. 1

  • Apply a minimum of 5 cmH₂O PEEP immediately after intubation in hypoxemic patients. 3

  • Perform a recruitment maneuver after intubation in hypoxemic patients. 3

Evidence-Based Selection Algorithms

Unstable Patients

  • Use etomidate (0.2–0.3 mg/kg) plus succinylcholine (1–1.5 mg/kg) to achieve rapid intubation with minimal hemodynamic impact. 1, 2

Stable Patients

  • Either etomidate or ketamine may be used for induction, combined with either succinylcholine or high-dose rocuronium (0.9–1.2 mg/kg); SCCM guidelines find no significant outcome differences among these options. 1, 2

Agitated/Combative Patients

  • Begin with ketamine (1–2 mg/kg IV) for medication-assisted pre-oxygenation, wait 3 minutes while applying oxygen, then proceed with the chosen NMBA once adequate dissociation is achieved. 1, 2, 3

Septic Shock Patients

  • Strongly prefer ketamine over etomidate in sepsis or septic shock, particularly in pediatric patients where etomidate is explicitly contraindicated due to adrenal suppression concerns. 1

Critical Pitfalls to Avoid

  • Do not delay intubation for prolonged optimization in severely distressed patients; postponement leads to rapid physiological decline and higher risk of cardiac arrest. 3

  • Do not use standard-sized endotracheal tubes in Down syndrome patients; select tubes 0.5–1.0 size smaller than age-predicted to accommodate the narrower trachea. 3

  • Do not assume absence of atlanto-axial instability in Down syndrome patients without recent imaging; treat every patient as potentially unstable. 3

  • Inadequate pre-oxygenation increases desaturation risk—ensure proper technique and consider medication-assisted pre-oxygenation for uncooperative patients. 2, 3

  • When using rocuronium, implement protocolized post-intubation analgosedation immediately to prevent awareness during the prolonged paralysis period. 1

References

Guideline

Rapid Sequence Intubation Medication Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Rapid Sequence Intubation Medication Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Rapid Sequence Intubation in Emergency Situations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the recommended procedure for rapid sequence intubation (RSI) in emergency situations?
What is the step‑by‑step procedure for performing endotracheal intubation with rapid‑sequence induction in an adult patient?
As a 22‑year‑old, how can I obtain a Do‑Not‑Resuscitate (DNR) order and what are the eligibility criteria?
What is the appropriate evaluation and initial management for a 19‑year‑old male with severe unexplained weight loss?
In a 19‑year‑old female with a three‑month history of progressive right‑temporal headache aggravated by coughing, cold exposure, bright light, and fan airflow, now accompanied by right‑sided painful ophthalmoplegia (intermittent diplopia that resolves when one eye is covered, medial deviation of the right eye, right upper‑eyelid ptosis, and retro‑orbital pain) and no fever or other systemic signs, what is the most likely diagnosis and what urgent investigations and initial management are recommended?
How should activity-related leg tremor be evaluated and managed?
In a patient with hepatocellular carcinoma receiving therapeutic heparin for a thrombus, is a tissue diagnosis (biopsy) necessary or recommended?
What are the indications, contraindications, and adverse effects of glycopyrrolate?
What are the current guidelines for mammography screening in average-risk women, including recommended starting age, frequency, and discontinuation criteria?
In a patient with known hepatocellular carcinoma who is receiving therapeutic heparin for a thrombus, is a liver biopsy indicated?
How long does a mandibular advancement device typically last?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.